The common theme of departmental research programs is molecular medicine:  that is, the elucidation of the pathogenesis of disease at the molecular level and the application of this knowledge to the design and implementation of novel therapies.  Our established programs include cancer biology, vascular biology, genetics, molecular hemostasis, amyloidogenesis and cholesterol metabolism.  Through collaborations with the Queen’s Cancer Research Institute we also have an emerging strength in translational research.

David Berman, MD, PhD

Professor
Biomarkers and therapeutic targets for bladder and prostate cancer

Tricia Cottrell, MD, PhD

Associate Professor
Tumour-immune interactions in solid tumours, and the identification of predictive and prognostic biomarkers in pre-treatment and post-treatment tumour tissues.

Scott Davey, PhD

Associate Professor
Basic and translational studies of the DNA damage response

Harriet Feilotter, PhD, FCCMG

Professor
Biomarkers to be used in the screening, diagnosis or treatment of huan diseases, including cancer

Peter Greer, PhD

Professor
Identification and validation of novel therapeutic targets in breast cancer

David Lillicrap, MD

Professor
Molecular hemostasis

Lois Mulligan, PhD

Professor
Role of the RET proto-oncogene in cancer

Christopher Nicol, PhD 

Associate Professor
Cell specific roles of PPARs in breast cancer

Anna Panchenko PhD

Professo, Canada Research Chair Tier 1
Computational Biology and Biophysics Lab

Michael Rauh, MD, PhD

Assistant Professor
Translational studies in myeloid blood cancers and innate immune tolerance

Neil Renwick, MD, PhD

Assistant Professor
Translational RNA Biology

Xiaolong Yang, PhD

Professor
The molecular and cellular funtion of tumor suppressors in human cancer